Complete BBL safety guide: how mortality dropped from 1:3,000 to 1:14,952, what the subcutaneous-only protocol means, risk comparison between BBL and butt implants, and the questions every patient must ask before scheduling.
In 2018, the American Society of Plastic Surgeons (ASPS) and ISAPS published an urgent advisory about the Brazilian Butt Lift: the estimated mortality rate was 1 in 3,000 procedures — the highest of any elective cosmetic surgery. The cause was technical, not conceptual: many surgeons were injecting fat inside the gluteal muscle, where large intramuscular veins could carry adipose tissue to the heart or lungs, causing fatal fat embolism.
The protocol change was not complex. Fat must be injected exclusively in the subcutaneous plane — above the muscle, never through it. The subcutaneous layer contains no large-caliber veins with direct connections to central venous circulation. Eliminating intramuscular injection eliminated the primary embolism pathway. The result of this single technical discipline change was a documented reduction in BBL mortality from 1:3,000 to approximately 1 in 14,952 procedures — now comparable with other elective surgeries of equivalent duration and anesthetic risk.
This improvement required no new technology. It required that surgeons use the correct technique consistently. Verifying that your surgeon does this is the most important safety action available to patients selecting a BBL provider.
Both techniques have distinct risk profiles. Understanding them is fundamental to informed consent
| Risk | BBL (fat transfer) | Butt implants |
|---|---|---|
| Fat embolism | Very low with correct subcutaneous protocol | Not applicable |
| Infection | Low (small liposuction incisions) | Higher risk (implant is a foreign body) |
| Asymmetry | Variable reabsorption can cause asymmetry | Implant displacement or rotation |
| Long-term complications | Low — stable fat integration | Capsular contracture, dehiscence. Rate >30% long-term |
| Sciatic nerve compression | Not applicable | Possible with malpositioned implant |
| Reintervention likelihood | Low if initial result is adequate | High long-term due to mechanical complications |
At ALMO Clinic, fat is injected exclusively in the subcutaneous adipose tissue — never inside the gluteal muscle. Cannulas with depth markers confirm tip position during injection. The surgeon maintains continuous tactile and visual control of the injection plane throughout the procedure.
This protocol is aligned with the updated guidelines of the ASPS, ISAPS, and the Colombian Society of Plastic Surgery (SCCP). It is not optional — it is the minimum standard for a BBL performed in 2026.
Not all patients are BBL candidates. We evaluate BMI, available fat volume, cardiovascular health, and history of biopolymer injections. Patients outside the safe BMI range, with a history of thrombosis, or with insufficient available fat are given a different recommendation — not a green light to proceed with a contraindicated procedure.
A candidate with unidentified contraindications is an avoidable risk. This is why a complete preoperative evaluation is not optional at ALMO Clinic — it is the basis of the surgical plan.
A surgeon practicing safe BBL answers these questions precisely, without evasion, and without impossible promises
Essential questions for any BBL candidate:
In which plane do you inject the fat — subcutaneous or intramuscular? How do you control cannula depth during injection? How many BBLs have you performed and what is your complication rate? Do you operate in a certified OR with a cardiovascular anesthesiologist? Is thromboembolic prophylaxis included in your protocol? What do you recommend if I don't have sufficient donor fat?
If a surgeon cannot answer these questions with precision, minimizes BBL risk by calling it "a simple, safe procedure," or cannot explain the injection plane distinction — these are disqualifying warning signs. The surgical skill that makes BBL safe is not mysterious; it is specific and explainable. A surgeon who performs it correctly has no reason to avoid the conversation.
Regardless of technique, gluteoplasty is a major surgery with inherent risks that must be part of the preoperative conversation. The most frequent are wound infection, hematoma or seroma, asymmetry from uneven fat reabsorption or implant displacement, and temporary changes in gluteal skin sensation.
In the BBL specifically, fat reabsorption is an expected biological phenomenon: between 30% and 40% of the transferred volume is reabsorbed in the first 3 months. The percentage that integrates permanently depends on factors the surgeon can optimize but not fully control: fat processing technique, transferred volume, post-operative protocol compliance, and individual biological response. Honest communication about this variability is part of what distinguishes a surgeon who respects informed consent from one who simply sells results.
We evaluate your case with full transparency: whether you're a candidate, which technique is appropriate, and the real risks for your specific anatomy. No commitment required.